CPT® Code 78429

Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single study; with concurrently acquired computed tomography transmission scan

A myocardial imaging, positron emission tomography (PET), metabolic evaluation study with a concurrently acquired computed tomography (CT) transmission scan is a sophisticated, non-invasive imaging procedure designed to assess the heart's muscle function and its ability to pump blood effectively. This study utilizes radioactive tracers, which are nucleotides injected into the patient's bloodstream, allowing for the visualization of the heart's metabolic activity through advanced computer graphics that generate three-dimensional images. The primary purpose of this PET scan is to detect biochemical changes within the heart cells, which can indicate the early stages of disease processes before any anatomical changes become apparent. This capability is particularly valuable in diagnosing conditions such as coronary artery disease and assessing heart muscle damage resulting from myocardial infarction. The left ventricle plays a crucial role in the circulatory system by pumping oxygen-rich blood to the body, and understanding its function is vital for evaluating cardiac health. The ejection fraction, which measures the percentage of blood ejected from the left ventricle during each contraction, along with the assessment of ventricular wall motion, are key indicators of left ventricular function. These measurements provide significant prognostic information regarding patient outcomes in the context of cardiac disease. The PET procedure is conducted in a specialized environment equipped with a proton (gamma ray) detecting scanner that encircles the patient's body. During the study, the patient is positioned on a movable table, and an intravenous (IV) line is established for the injection of the radioactive tracer. Electrocardiogram (EKG) leads are attached to monitor the heart's electrical activity and synchronize the imaging process. Initially, a baseline CT scan is performed as the table moves through the scanner, capturing essential data over a few minutes. Following this, the radioactive tracer is administered, and the table moves through the scanner at a slower pace to collect PET data, resulting in images of the heart from various angles. The distribution of the radioactive tracer within the heart tissue varies based on blood flow, allowing for the identification of narrowed coronary vessels, damaged tissue, and scar tissue, which are represented by distinct patterns and colors on the generated 3D images. The simultaneous acquisition of PET and CT data enhances the precision of anatomical localization of any damaged tissue or disease processes by utilizing a CT map to correct for soft tissue attenuation.